Local News US FDA Grants Regular Approval and Expands Indication for PADCEV®Seagen | July 13, 2021Seagen Inc. (Nasdaq:SGEN) and Astellas Pharma Inc. (TSE: 4503, President and CEO: Kenji Yasukawa, Ph.D.,…kchenJuly 13, 2021 Read More
Local News Seattle Children’s Pioneering Immunotherapy Trial May Be Feasible to Combat Pediatric Brain and Spinal Cord TumorsSeattle Children’s | July 13, 2021An innovative clinical trial led by Dr. Nicholas Vitanza, a neuro-oncologist at Seattle Children’s, shows…kchenJuly 13, 2021 Read More
Local News Silverback Therapeutics Announces Clinical Supply Agreement with Regeneron to Evaluate SBT6050 in Combination with LibtayoBusiness Wire | July 9, 2021Silverback Therapeutics, Inc. (Nasdaq: SBTX) (“Silverback”), a clinical-stage biopharmaceutical company leveraging its proprietary ImmunoTAC technology…kchenJuly 9, 2021 Read More
Local News Epsilon Variant Mutations Help Spur COVID Immune EvasionUW Medicine Newsroom | July 9, 2021Three mutations in the Epsilon coronavirus spike protein dampen the neutralizing potency of antibodies induced…kchenJuly 9, 2021 Read More
Local News Icosavax, Which Is Developing COVID-19 Vaccines, Files for IPOGeekWire | July 8, 2021Seattle-based Icosavax has filed to go public via an IPO, just four years after it launched out…kchenJuly 8, 2021 Read More
Local News Seattle’s HDT Bio to Start US Clinical Trials of Its COVID-19 Vaccine CandidateGeekWire | July 8, 2021An experimental COVID-19 vaccine in development by Seattle-based HDT Bio will enter early-stage clinical trials in the…kchenJuly 8, 2021 Read More
Local News HDT Bio Receives Notice to Proceed from FDA for US Phase 1 Clinical Trial of RNA COVID-19 VaccineHDT Bio | July 6, 2021HDT Bio Corp., a developer of immunotherapies for oncology and infectious diseases today announced the…kchenJuly 6, 2021 Read More
Local News Looking at Tumors through a New LensInstitute for Systems Biology | July 2, 2021Neoadjuvant immune checkpoint blockade (ICB) is a promising treatment for melanoma and other cancer types,…kchenJuly 2, 2021 Read More
Local News Achieve Announces Completion of Target Enrollment in Phase 3 ORCA-2 Smoking Cessation Trial of CytisiniclineAchieve Life Sciences | July 2, 2021Achieve Life Sciences, Inc. (Nasdaq: ACHV), a clinical-stage pharmaceutical company committed to the global development…kchenJuly 2, 2021 Read More
Local News Alpine Immune Sciences to Collaborate with Merck on Immuno-Oncology StudyAlpine Immune Sciences | July 1, 2021Alpine Immune Sciences, Inc. (NASDAQ: ALPN), a leading clinical-stage immunotherapy company focused on developing innovative treatments…kchenJuly 1, 2021 Read More